MCA-GL-117 — Version 1, 19 June 2026
MCA-GL-117 — Version 1, 19 June 2026 is the official MCA identifier for “Guideline for Listing of Medicines and Related Products”. MCA-GL-117 — Version 1, 19 June 2026 is the official identifier MCA uses for this instrument.
- Instrument
- MCA-GL-117
- Full name
- MCA-GL-117 — Version 1, 19 June 2026
- Category
- Registration
- Source publication
- English
- Readable HTML
- 1 language version
- Published
- —
- Effective
- 2026-06-19
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Guideline for Listing of Medicines and Related Products
Complete current MCA listing guideline, approved and effective 19 June 2026. Expressly replaces the earlier guidance to manufacturers, marketing-authorisation holders and importers. Covers listing eligibility, medical devices, application processes, annexes and the reference-country appendix. It cites an amendment Act as 2025, while the earlier guidance and Assembly catalogue refer to 2023; that statutory identity requires separate verification.
MCA-GL-117 — Version 1, 19 June 2026 is the official identifier MCA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.